Have a personal or library account? Click to login
Restless Legs Syndrome: Current Concepts about Disease Pathophysiology Cover

Restless Legs Syndrome: Current Concepts about Disease Pathophysiology

Open Access
|Jul 2016

References

  1. 1
    AllenRPWaltersASMontplaisirJet alRestless legs syndrome prevalence and impact: REST general population studyArch Intern Med200516512861292doi: 10.1001/archinte.165.11.128615956009
  2. 2
    AllenRPBharmalMCallowayMPrevalence and disease burden of primary restless legs syndrome: results of a general population survey in the United StatesMov Disord201126114120doi: 10.1002/mds.2343021322022
  3. 3
    HeningWWaltersASAllenRPMontplaisirJMyersAFerini-StrambiLImpact, diagnosis and treatment of restless legs syndrome (RLS) in a primary care population: the REST (RLS epidemiology, symptoms, and treatment) primary care studySleep Med20045237246doi: 10.1016/j.sleep.2004.03.00615165529
  4. 4
    AllenRPStillmanPMyersAJPhysician-diagnosed restless legs syndrome in a large sample of primary medical care patients in Western Europe: prevalence and characteristicsSleep Med2010113137doi: 10.1016/j.sleep.2009.03.00719464949
  5. 5
    Garcia-BorregueroDLarrosaOde la LlaveYGranizoJJAllenRCorrelation between rating scales and sleep laboratory measurements in restless legs syndromeSleep Med20045561565doi: 10.1016/j.sleep.2004.08.00315511702
  6. 6
    MontplaisirJBoucherSPoirierGLavigneGLapierreOLesperancePClinical, polysomnographic, and genetic characteristics of restless legs syndrome: a study of 133 patients diagnosed with new standard criteriaMov Disord1997126165doi: 10.1002/mds.8701201118990055
  7. 7
    CelleSRocheFKerlerouxJet alPrevalence and clinical correlates of restless legs syndrome in an elderly French population: the synapse studyJ Gerontol A Biol Sci Med Sci201065167173doi: 10.1093/gerona/glp16119914971
  8. 8
    HornyakMKopaszMBergerMRiemannDVoderholzerUImpact of sleep-related complaints on depressive symptoms in patients with restless legs syndromeJ Clin Psychiatry20056611391145doi: 10.4088/JCP.v66n090916187772
  9. 9
    KimWHKimBSKimSKet alRestless legs syndrome in older people: a community-based study on its prevalence and association with major depressive disorder in older Korean adultsInt J Geriatr Psychiatry201227565572doi: 10.1002/gps.275421826739
  10. 10
    BayardSLangenierMCDauvilliersYDecision-making, reward-seeking behaviors and dopamine agonist therapy in restless legs syndromeSleep20133615011507doi: 10.5665/sleep.304424082309
  11. 11
    BucherSFTrenkwalderCOertelWHReflex studies and MRI in the restless legs syndromeActa Neurol Scand199694145150doi: 10.1111/j.1600-0404.1996.tb07045.x8891061
  12. 12
    AllenRPBarkerPBWehrlFWSongHKEarleyCJMRI measurement of brain iron in patients with restless legs syndromeNeurology200156263265doi: 10.1212/WNL.56.2.26311160969
  13. 13
    EarleyCJB BarkerPHorskaAAllenRPMRI-determined regional brain iron concentrations in early- and late-onset restless legs syndromeSleep Med20067458461doi: 10.1016/j.sleep.2005.11.00916740411
  14. 14
    GodauJKloseUDi SantoASchweitzerKBergDMultiregional brain iron deficiency in restless legs syndromeMov Disord20082311841187doi: 10.1002/mds.2207018442125
  15. 15
    ConnorJRBoyerPJMenziesSLet alNeuropathological examination suggests impaired brain iron acquisition in restless legs syndromeNeurology200361304309doi: 10.1212/01.WNL.0000078887.16593.1212913188
  16. 16
    ConnorJRPonnuruPWangXSPattonSMAllenRPEarleyCJProfile of altered brain iron acquisition in restless legs syndromeBrain2011134(Pt 4)959968doi: 10.1093/brain/awr01221398376
  17. 17
    BucherSFSeelosKCOertelWHReiserMTrenkwalderCCerebral generators involved in the pathogenesis of the restless legs syndromeAnn Neurol199741639645doi: 10.1002/ana.4104105139153526
  18. 18
    MargaritiPNAstrakasLGTsouliSGHadjigeorgiouGMKonitsiotisSArgyropoulouMIInvestigation of unmedicated early onset restless legs syndrome by voxel-based morphometry, T2 relaxometry, and functional MR imaging during the night-time hoursAJNR Am J Neuroradiol201233667672doi: 10.3174/ajnr.A282922173758
  19. 19
    AstrakasLGKonitsiotisSMargaritiPTsouliSTzarouhiLArgyropoulouMIT2 relaxometry and fMRI of the brain in late-onset restless legs syndromeNeurology200871911916doi: 10.1212/01.wnl.0000325914.50764.a218794493
  20. 20
    MoonHJChangYLeeYSet alT2 relaxometry using 3.0-tesla magnetic resonance imaging of the brain in early- and late-onset restless legs syndromeJ Clin Neurol201410197202doi: 10.3988/jcn.2014.10.3.19725045371
  21. 21
    MoonHJChangYLeeYSet alA comparison of MRI tissue relaxometry and ROI methods used to determine regional brain iron concentrations in restless legs syndromeMed Devices (Auckl)2015834135026257527
  22. 22
    RizzoGMannersDTestaCet alLow brain iron content in idiopathic restless legs syndrome patients detected by phase imagingMov Disord20132818861890doi: 10.1002/mds.2557623780623
  23. 23
    EisensehrIWetterTCLinkeRet alNormal IPT and IBZM SPECT in drug-naive and levodopa-treated idiopathic restless legs syndromeNeurology20015713071309doi: 10.1212/WNL.57.7.130711591854
  24. 24
    MichaudMSoucyJPChabliALavigneGMontplaisirJSPECT imaging of striatal pre- and postsynaptic dopaminergic status in restless legs syndrome with periodic leg movements in sleepJ Neurol2002249164170doi: 10.1007/PL0000785911985381
  25. 25
    TriblGGAsenbaumSHappeSBonelliRMZeitlhoferJAuffENormal striatal D2 receptor binding in idiopathic restless legs syndrome with periodic leg movements in sleepNucl Med Commun2004255560doi: 10.1097/00006231-200401000-0000815061265
  26. 26
    KimKWJhooJHLeeSBet alIncreased striatal dopamine transporter density in moderately severe old restless legs syndrome patientsEur J Neurol20121912131218doi: 10.1111/j.1468-1331.2012.03705.x22435397
  27. 27
    ChangYChangHWSongHet alGray matter alteration in patients with restless legs syndrome: a voxel-based morphometry studyClin Imaging2015392025doi: 10.1016/j.clinimag.2014.07.01025176196
  28. 28
    HornyakMAhrendtsJCSpiegelhalderKet alVoxel-based morphometry in unmedicated patients with restless legs syndromeSleep Med200792226doi: 10.1016/j.sleep.2006.09.01017512782
  29. 29
    CelleSRocheFPeyronRet alLack of specific gray matter alterations in restless legs syndrome in elderly subjectsJ Neurol2010257344348doi: 10.1007/s00415-009-5320-219768657
  30. 30
    MagalhaesSCKaelin-LangASterrAdo PradoGFEckeliALConfortoABTranscranial magnetic stimulation for evaluation of motor cortical excitability in restless legs syndrome/Willis-Ekbom diseaseSleep Med20151612651273doi: 10.1016/j.sleep.2015.03.01826429756
  31. 31
    UnrathAJuenglingFDSchorkMKassubekJCortical grey matter alterations in idiopathic restless legs syndrome: an optimized voxel-based morphometry studyMov Disord20072217511756doi: 10.1002/mds.2160817566123
  32. 32
    PanPLDaiZYShangHFet alGray matter anomalies in anterior cingulate cortex as a correlate of depressive symptoms in drug-naive idiopathic restless legs syndromeNeuroscience201427715doi: 10.1016/j.neuroscience.2014.06.04524993478
  33. 33
    ConnorJRPonnuruPLeeBYet alPostmortem and imaging based analyses reveal CNS decreased myelination in restless legs syndromeSleep Med201112614619doi: 10.1016/j.sleep.2010.10.00921570342
  34. 34
    ComleyRACervenkaSPalhagenSEet alA comparison of gray matter density in restless legs syndrome patients and matched controls using voxel-based morphometryJ Neuroimaging2012222832doi: 10.1111/j.1552-6569.2010.00536.x21091816
  35. 35
    ConnorJRWangXSPattonSMet alDecreased transferrin receptor expression by neuromelanin cells in restless legs syndromeNeurology20046215631567doi: 10.1212/01.WNL.0000123251.60485.AC15136682
  36. 36
    TurjanskiNLeesAJBrooksDJStriatal dopaminergic function in restless legs syndrome: 18F-dopa and 11C-raclopride PET studiesNeurology199952932937doi: 10.1212/WNL.52.5.93210102408
  37. 37
    ConnorJRWangXSAllenRPet alAltered dopaminergic profile in the putamen and substantia nigra in restless leg syndromeBrain2009132(Pt 9)24032412doi: 10.1093/brain/awp12519467991
  38. 38
    JhooJHYoonIYKimYKet alAvailability of brain serotonin transporters in patients with restless legs syndromeNeurology201074513518doi: 10.1212/WNL.0b013e3181cef82420142619
  39. 39
    EtgenTDraganskiBIlgCet alBilateral thalamic gray matter changes in patients with restless legs syndromeNeuroimage20052412421247doi: 10.1016/j.neuroimage.2004.10.02115670702
  40. 40
    AllenRPBarkerPBHorskaAEarleyCJThalamic glutamate/glutamine in restless legs syndrome: increased and related to disturbed sleepNeurology20138020282034doi: 10.1212/WNL.0b013e318294b3f623624560
  41. 41
    WaltersASOndoWGZhuWLeWDoes the endogenous opiate system play a role in the Restless Legs Syndrome? A pilot post-mortem studyJ Neurol Sci20092796265doi: 10.1016/j.jns.2008.12.02219167016
  42. 42
    KuJChoYWLeeYSet alFunctional connectivity alternation of the thalamus in restless legs syndrome patients during the asymptomatic period: a resting-state connectivity study using functional magnetic resonance imagingSleep Med201415289294doi: 10.1016/j.sleep.2013.09.03024555993
  43. 43
    RizzoGTononCTestaCet alAbnormal medial thalamic metabolism in patients with idiopathic restless legs syndromeBrain2012135(Pt 12)37123720doi: 10.1093/brain/aws26623183234
  44. 44
    MagnussonKRClementsJRLarsonAAMadlJEBeitzAJLocalization of glutamate in trigeminothalamic projection neurons: a combined retrograde transport-immunohistochemical studySomatosens Res19874177190doi: 10.3109/073672287091446052882592
  45. 45
    McCormickDAvon KrosigkMCorticothalamic activation modulates thalamic firing through glutamate “metabotropic” receptorsProc Natl Acad Sci USA19928927742778doi: 10.1073/pnas.89.7.27741313567
  46. 46
    FerriRRundoFZucconiMet alAn evidence-based analysis of the association between periodic leg movements during sleep and arousals in restless legs syndromeSleep2015381924doi: 10.1016/j.sleep.2006.01.004
  47. 47
    WinkelmanJWRedlineSBaldwinCMResnickHENewmanABGottliebDJPolysomnographic and health-related quality of life correlates of restless legs syndrome in the Sleep Heart Health StudySleep20093277277819544754
  48. 48
    WinkelmanJWFinnLYoungTPrevalence and correlates of restless legs syndrome symptoms in the Wisconsin sleep cohortSleep Med20067545552doi: 10.1016/j.sleep.2006.01.00416740407
  49. 49
    LeeHBHeningWAAllenRPet alRestless legs syndrome is associated with DSM-IV major depressive disorder and panic disorder in the communityJ Neuropsychiatry Clin Neurosci200820101105doi: 10.1176/jnp.2008.20.1.10118305292
  50. 50
    RyeDBTrottiLMRestless legs syndrome and periodic leg movements of sleepNeurol Clin20123011371166doi: 10.1016/j.ncl.2012.08.00423099132
  51. 51
    TrenkwalderCBucherSFOertelWHElectrophysiological pattern of involuntary limb movements in the restless legs syndromeMuscle Nerve199619155162doi: 10.1002/(SICI)1097-4598(199602)19:2<155::AID-MUS5>3.0.CO;2-D8559163
  52. 52
    AksuMDemirciSBara-JimenezWCorrelation between putative indicators of primary restless legs syndrome severitySleep Med200788489doi: 10.1016/j.sleep.2005.12.00116740410
  53. 53
    FrauscherBLoscherWHoglBPoeweWKoflerMAuditory startle reaction is disinhibited in idiopathic restless legs syndromeSleep200730(4)48949317520793
  54. 54
    MoskoSSNudlemanKLSomatosensory and brainstem auditory evoked responses in sleep-related periodic leg movementsSleep198693994043764287
  55. 55
    AkyolAKiyliogluNKadikoyluGBolamanAZOzgelNIron deficiency anemia and restless legs syndrome: is there an electrophysiological abnormality?Clin Neurol Neurosurg20031062327doi: 10.1016/j.clineuro.2003.07.00414643912
  56. 56
    Stiasny-KolsterKMollerJCZschockeJet alNormal dopaminergic and serotonergic metabolites in cerebrospinal fluid and blood of restless legs syndrome patientsMov Disord200419192196doi: 10.1002/mds.1063114978675
  57. 57
    AllenRPConnorJRHylandKEarleyCJAbnormally increased CSF 3-Ortho-methyldopa (3-OMD) in untreated restless legs syndrome (RLS) patients indicates more severe disease and possibly abnormally increased dopamine synthesisSleep Med200910123128doi: 10.1016/j.sleep.2007.11.01218226951
  58. 58
    CervenkaSPalhagenSEComleyRAet alSupport for dopaminergic hypoactivity in restless legs syndrome: a PET study on D2-receptor bindingBrain2006129(Pt 8)20172028doi: 10.1093/brain/awl16316816393
  59. 59
    EarleyCJKuwabaraHWongDFet alIncreased synaptic dopamine in the putamen in restless legs syndromeSleep2013365157doi: 10.5665/sleep.230023288971
  60. 60
    EarleyCJKuwabaraHWongDFet alThe dopamine transporter is decreased in the striatum of subjects with restless legs syndromeSleep20113434134721358851
  61. 61
    AllenRPEarleyCJAugmentation of the restless legs syndrome with carbidopa/levodopaSleep1996192052138723377
  62. 62
    SunERChenCAHoGEarleyCJAllenRPIron and the restless legs syndromeSleep1998213713779646381
  63. 63
    KrygerMHOtakeKFoersterJLow body stores of iron and restless legs syndrome: a correctable cause of insomnia in adolescents and teenagersSleep Med20023127132doi: 10.1016/S1389-9457(01)00160-514592231
  64. 64
    WangJO’ReillyBVenkataramanRMysliwiecVMysliwiecAEfficacy of oral iron in patients with restless legs syndrome and a low-normal ferritin: a randomized, double-blind, placebo-controlled studySleep Med200910973975doi: 10.1016/j.sleep.2008.11.00319230757
  65. 65
    EarleyCJHecklerDAllenRPThe treatment of restless legs syndrome with intravenous iron dextranSleep Med20045231235doi: 10.1016/j.sleep.2004.03.00215165528
  66. 66
    EarleyCJConnorJRBeardJLMaleckiEAEpsteinDKAllenRPAbnormalities in CSF concentrations of ferritin and transferrin in restless legs syndromeNeurology20005416981700doi: 10.1212/WNL.54.8.169810762522
  67. 67
    BurdoJRMenziesSLSimpsonIAet alDistribution of divalent metal transporter 1 and metal transport protein 1 in the normal and Belgrade ratJ Neurosci Res20016611981207doi: 10.1002/jnr.125611746453
  68. 68
    AbboudSHaileDJA novel mammalian iron-regulated protein involved in intracellular iron metabolismJ Biol Chem20002751990619912doi: 10.1074/jbc.M00071320010747949
  69. 69
    WaltersASReview of receptor agonist and antagonist studies relevant to the opiate system in restless legs syndromeSleep Med20023301304doi: 10.1016/S1389-9457(02)00011-414592191
  70. 70
    WaltersASWagnerMLHeningWAet alSuccessful treatment of the idiopathic restless legs syndrome in a randomized double-blind trial of oxycodone versus placeboSleep1993163273328341893
  71. 71
    OndoWGMethadone for refractory restless legs syndromeMov Disord200520345348doi: 10.1002/mds.2035915580610
  72. 72
    DeandradeMUngerEZhangLYokoiFWaltersALiYHyperactivity and alterations in iron homeostasis in mu opioid receptor knockout mice: possible implications for restless legs syndrome/Willis-Ekbom diseaseWorld Association of Sleep Medicine Congress 2013, Valencia, Spain, Oct 1, 2013
  73. 73
    SunYMHoangTNeubauerJAWaltersASOpioids protect against substantia nigra cell degeneration under conditions of iron deprivation: a mechanism of possible relevance to the Restless Legs Syndrome (RLS) and Parkinson’s diseaseJ Neurol Sci201130493101doi: 10.1016/j.jns.2011.02.00321376342
  74. 74
    CoulonPBuddeTPapeHCThe sleep relay – the role of the thalamus in central and decentral sleep regulationPflugers Arch20124635371doi: 10.1007/s00424-011-1014-621912835
  75. 75
    SaletuMAndererPSaletu-ZyhlarzGMet alComparative placebo-controlled polysomnographic and psychometric studies on the acute effects of gabapentin versus ropinirole in restless legs syndromeJ Neural Transm (Vienna)2010117463473doi: 10.1007/s00702-009-0361-320049491
  76. 76
    RoseMAKamPCGabapentin: pharmacology and its use in pain managementAnaesthesia200257451462doi: 10.1046/j.0003-2409.2001.02399.x11966555
  77. 77
    GajrajNMPregabalin: its pharmacology and use in pain managementAnesth Analg200710518051815doi: 10.1213/01.ane.0000287643.13410.5e18042886
  78. 78
    PageRL2ndRuscinJMBainbridgeJLBriekeAARestless legs syndrome induced by escitalopram: case report and review of the literaturePharmacotherapy200828271280doi: 10.1592/phco.28.2.27118225972
  79. 79
    RottachKGSchanerBMKirchMHet alRestless legs syndrome as side effect of second generation antidepressantsJ Psychiatr Res2008437075doi: 10.1016/j.jpsychires.2008.02.00618468624
  80. 80
    OhayonMMRothTPrevalence of restless legs syndrome and periodic limb movement disorder in the general populationJ Psychosom Res200253547554doi: 10.1016/S0022-3999(02)00443-912127170
  81. 81
    YangCWhiteDPWinkelmanJWAntidepressants and periodic leg movements of sleepBiol Psychiatry200558510514doi: 10.1016/j.biopsych.2005.04.02216005440
  82. 82
    SalminenAVRimpilaVPoloOPeripheral hypoxia in restless legs syndrome (Willis-Ekbom disease)Neurology20148218561861doi: 10.1212/WNL.000000000000045424789861
  83. 83
    PattonSMPonnuruPSnyderAMPodskalnyGDConnorJRHypoxia-inducible factor pathway activation in restless legs syndrome patientsEur J Neurol20111813291335doi: 10.1111/j.1468-1331.2011.03397.x21985026
  84. 84
    SchnellPOIgnacakMLBauerALStrietJBPauldingWRCzyzyk-KrzeskaMFRegulation of tyrosine hydroxylase promoter activity by the von Hippel-Lindau tumor suppressor protein and hypoxia-inducible transcription factorsJ Neurochem200385483491doi: 10.1046/j.1471-4159.2003.01696.x12675925
  85. 85
    BachmannCGRolkeRScheidtUet alThermal hypoaesthesia differentiates secondary restless legs syndrome associated with small fibre neuropathy from primary restless legs syndromeBrain2010133Pt 3762770doi: 10.1093/brain/awq02620194142
  86. 86
    Stiasny-KolsterKMagerlWOertelWHMollerJCTreedeRDStatic mechanical hyperalgesia without dynamic tactile allodynia in patients with restless legs syndromeBrain2004127(Pt 4)773782doi: 10.1093/brain/awh07914985260
  87. 87
    SchattschneiderJBodeAWasnerGBinderADeuschlGBaronRIdiopathic restless legs syndrome: abnormalities in central somatosensory processingJ Neurol2004251977982doi: 10.1007/s00415-004-0475-315316803
  88. 88
    LimYMChangSEChungSKangBHKimKKSmall fiber function in drug naive patients with idiopathic restless legs syndromeJ Clin Neurosci201219702705doi: 10.1016/j.jocn.2011.07.04322364890
  89. 89
    TyvaertLLaureauEHurteventJPHurteventJFDeramburePMonacaCA-delta and C-fibres function in primary restless legs syndromeNeurophysiol Clin200939267274doi: 10.1016/j.neucli.2009.06.00319962654
  90. 90
    IsakBUlucKSalciniCAganKTanridagTUsOA neurophysiological approach to the complex organisation of the spine: f-wave duration and the cutaneous silent period in restless legs syndromeClin Neurophysiol2011122383390doi: 10.1016/j.clinph.2010.07.00520724211
  91. 91
    PolydefkisMAllenRPHauerPEarleyCJGriffinJWMcArthurJCSubclinical sensory neuropathy in late-onset restless legs syndromeNeurology20005511151121doi: 10.1212/WNL.55.8.111511071488
  92. 92
    BertischSMMuresanCSchoerningLWinkelmanJWTaylorJAImpact of restless legs syndrome on cardiovascular autonomic controlSleep201639565571doi: 10.5665/sleep.552826564128
  93. 93
    Bara-JimenezWAksuMGrahamBSatoSHallettMPeriodic limb movements in sleep: state-dependent excitability of the spinal flexor reflexNeurology20005416091616doi: 10.1212/WNL.54.8.160910762502
  94. 94
    PennestriMHMontplaisirJColomboRLavigneGLanfranchiPANocturnal blood pressure changes in patients with restless legs syndromeNeurology20076812131218doi: 10.1212/01.wnl.0000259036.89411.5217420405
  95. 95
    SiddiquiFStrusJMingXLeeIAChokrovertySWaltersASRise of blood pressure with periodic limb movements in sleep and wakefulnessClin Neurophysiol200711819231930doi: 10.1016/j.clinph.2007.05.00617588809
  96. 96
    IzziFPlacidiFRomigiAet alIs autonomic nervous system involved in restless legs syndrome during wakefulness?Sleep Med20141513921397doi: 10.1016/j.sleep.2014.06.02225266501
  97. 97
    Ferini-StrambiLWaltersASSicaDThe relationship among restless legs syndrome (Willis-Ekbom Disease), hypertension, cardiovascular disease, and cerebrovascular diseaseJ Neurol201426110511068doi: 10.1007/s00415-013-7065-123963470
  98. 98
    DesaiAVCherkasLFSpectorTDWilliamsAJGenetic influences in self-reported symptoms of obstructive sleep apnoea and restless legs: a twin studyTwin Res20047589595doi: 10.1375/136905204266384115607009
  99. 99
    OndoWGVuongKDWangQRestless legs syndrome in monozygotic twins: clinical correlatesNeurology20005514041406doi: 10.1212/WNL.55.9.140411087794
  100. 100
    PichlerIHicksAAPramstallerPPRestless legs syndrome: an update on genetics and future perspectivesClin Genet200873297305doi: 10.1111/j.1399-0004.2007.00937.x18070136
  101. 101
    WinkelmannJGenetics of restless legs syndromeCurr Neurol Neurosci Rep20088211216doi: 10.1007/s11910-008-0033-y18541116
  102. 102
    StefanssonHRyeDBHicksAet alA genetic risk factor for periodic limb movements in sleepN Engl J Med2007357(7)639647doi: 10.1056/NEJMoa07274317634447
  103. 103
    WinkelmannJSchormairBLichtnerPet alGenome-wide association study of restless legs syndrome identifies common variants in three genomic regionsNat Genet20073910001006doi: 10.1038/ng209917637780
  104. 104
    SchormairBKemlinkDRoeskeDet alPTPRD (protein tyrosine phosphatase receptor type delta) is associated with restless legs syndromeNat Genet200840946948doi: 10.1038/ng.19018660810
  105. 105
    YangQLiLChenQFoldvary-SchaeferNOndoWGWangQKAssociation studies of variants in MEIS1, BTBD9, and MAP2K5/SKOR1 with restless legs syndrome in a US populationSleep Med201112800804doi: 10.1016/j.sleep.2011.06.00621925394
  106. 106
    MooreH4thWinkelmannJLinLFinnLPeppardPMignotEPeriodic leg movements during sleep are associated with polymorphisms in BTBD9, TOX3/BC034767, MEIS1, MAP2K5/SKOR1, and PTPRDSleep20143715351542doi: 10.5665/sleep.400625142570
  107. 107
    FreemanAPranskiEMillerRDet alSleep fragmentation and motor restlessness in a Drosophila model of Restless Legs SyndromeCurr Biol20122211421148doi: 10.1016/j.cub.2012.04.02722658601
  108. 108
    DeAndradeMPJohnsonRLJrUngerELet alMotor restlessness, sleep disturbances, thermal sensory alterations and elevated serum iron levels in Btbd9 mutant miceHum Mol Genet20122139843992doi: 10.1093/hmg/dds22122678064
  109. 109
    BaranASRichertACDouglassABMayWAnsarinKChange in periodic limb movement index during treatment of obstructive sleep apnea with continuous positive airway pressureSleep20032671772014572125
  110. 110
    BoivinDBLorrainDMontplaisirJEffects of bromocriptine on periodic limb movements in human narcolepsyNeurology19934321342136doi: 10.1212/WNL.43.10.21348413980
  111. 111
    KooBBBlackwellTAncoli-IsraelSStoneKLStefanickMLRedlineSAssociation of incident cardiovascular disease with periodic limb movements during sleep in older men: outcomes of sleep disorders in older men (MrOS) studyCirculation201112412231231doi: 10.1161/CIRCULATIONAHA.111.03896821859975
  112. 112
    HeningWAAllenRPWashburnMLesageSREarleyCJThe four diagnostic criteria for Restless Legs Syndrome are unable to exclude confounding conditions (“mimics”)Sleep Med200910976981doi: 10.1016/j.sleep.2008.09.01519185537
  113. 113
    KemlinkDPoloOFrauscherBet alReplication of restless legs syndrome loci in three European populationsJ Med Genet200946315318doi: 10.1136/jmg.2008.06299219279021
  114. 114
    KimMKChoYWShinWCet alAssociation of restless legs syndrome variants in Korean patients with restless legs syndromeSleep20133617871791doi: 10.5665/sleep.320024293752
  115. 115
    YangQLiLYangRet alFamily-based and population-based association studies validate PTPRD as a risk factor for restless legs syndromeMov Disord201126516519doi: 10.1002/mds.2345921264940
  116. 116
    WinkelmannJCzamaraDSchormairBet alGenome-wide association study identifies novel restless legs syndrome susceptibility loci on 2p14 and 16q12.1PLoS Genet20117e1002171doi: 10.1371/journal.pgen.100217121779176
  117. 117
    Rataj-BaniowskaMNiewiadomska-CimickaAPaschakiMet alRetinoic acid receptor beta controls development of striatonigral projection neurons through FGF-dependent and Meis1-dependent mechanismsJ Neurosci2015351446714475doi: 10.1523/JNEUROSCI.1278-15.201526511239
  118. 118
    CatoireHDionPAXiongLet alRestless legs syndrome-associated MEIS1 risk variant influences iron homeostasisAnn Neurol201170170175doi: 10.1002/ana.2243521710629
  119. 119
    SpielerDKaffeMKnaufFet alRestless legs syndrome-associated intronic common variant in Meis1 alters enhancer function in the developing telencephalonGenome Res201424592603doi: 10.1101/gr.166751.11324642863
  120. 120
    BeardJLChenQConnorJJonesBCAltered monamine metabolism in caudate-putamen of iron-deficient ratsPharmacol Biochem Behav199448621624doi: 10.1016/0091-3057(94)90323-97524105
  121. 121
    EriksonKMJonesBCBeardJLIron deficiency alters dopamine transporter functioning in rat striatumJ Nutr20001302831283711053528
  122. 122
    LimJKimHIBangYSeolWChoiHSChoiHJHypoxia-inducible factor-1alpha upregulates tyrosine hydroxylase and dopamine transporter by nuclear receptor ERRgamma in SH-SY5Y cellsNeuroreport201526380386doi: 10.1097/WNR.000000000000035625807177
  123. 123
    Wahlin-LarssonBUlfbergJAulinKPKadiFThe expression of vascular endothelial growth factor in skeletal muscle of patients with sleep disordersMuscle Nerve200940556561doi: 10.1002/mus.2135719623635
  124. 124
    Wahlin LarssonBKadiFUlfbergJPiehl AulinKSkeletal muscle morphology and aerobic capacity in patients with obstructive sleep apnoea syndromeRespiration2008762127doi: 10.1159/00012649218408358
  125. 125
    SemenzaGLInvolvement of oxygen-sensing pathways in physiologic and pathologic erythropoiesisBlood200911420152019doi: 10.1182/blood-2009-05-18998519494350
DOI: https://doi.org/10.5334/tohm.322 | Journal eISSN: 2160-8288
Language: English
Submitted on: Apr 20, 2016
Accepted on: Jun 7, 2016
Published on: Jul 22, 2016
Published by: Columbia University Libraries/Information Services
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2016 Brian B. Koo, Kanika Bagai, Arthur S. Walters, published by Columbia University Libraries/Information Services
This work is licensed under the Creative Commons License.